These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19858019)

  • 41. Genotype-phenotype correlations in individuals with a founder mutation in the MLH1 gene and hereditary non-polyposis colorectal cancer.
    de Leon MP; Benatti P; Di Gregorio C; Losi L; Pedroni M; Ponti G; Genuardi M; Viel A; Lucci-Cordisco E; Rossi G; Roncucci L
    Scand J Gastroenterol; 2007 Jun; 42(6):746-53. PubMed ID: 17505997
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential cancer predisposition in Lynch syndrome: insights from molecular analysis of brain and urinary tract tumors.
    Gylling AH; Nieminen TT; Abdel-Rahman WM; Nuorva K; Juhola M; Joensuu EI; Järvinen HJ; Mecklin JP; Aarnio M; Peltomäki PT
    Carcinogenesis; 2008 Jul; 29(7):1351-9. PubMed ID: 18550572
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Frequency of hereditary non-polyposis colorectal cancer among unselected patients with colorectal cancer in Germany.
    Lamberti C; Mangold E; Pagenstecher C; Jungck M; Schwering D; Bollmann M; Vogel J; Kindermann D; Nikorowitsch R; Friedrichs N; Schneider B; Houshdaran F; Schmidt-Wolf IG; Friedl W; Propping P; Sauerbruch T; Büttner R; Mathiak M
    Digestion; 2006; 74(1):58-67. PubMed ID: 17095871
    [TBL] [Abstract][Full Text] [Related]  

  • 44. One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome.
    Vasen HF; Abdirahman M; Brohet R; Langers AM; Kleibeuker JH; van Kouwen M; Koornstra JJ; Boot H; Cats A; Dekker E; Sanduleanu S; Poley JW; Hardwick JC; de Vos Tot Nederveen Cappel WH; van der Meulen-de Jong AE; Tan TG; Jacobs MA; Mohamed FL; de Boer SY; van de Meeberg PC; Verhulst ML; Salemans JM; van Bentem N; Westerveld BD; Vecht J; Nagengast FM
    Gastroenterology; 2010 Jun; 138(7):2300-6. PubMed ID: 20206180
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families.
    Wahlberg SS; Schmeits J; Thomas G; Loda M; Garber J; Syngal S; Kolodner RD; Fox E
    Cancer Res; 2002 Jun; 62(12):3485-92. PubMed ID: 12067992
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Our experience with the incidence of hereditary non-polyposis colorectal cancer].
    Tanyi M
    Magy Seb; 2009 Apr; 62(2):87-94. PubMed ID: 19386570
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hereditary gastrointestinal cancer.
    Hata K; Yamamoto Y; Kiyomatsu T; Tanaka T; Kazama S; Nozawa H; Kawai K; Tanaka J; Nishikawa T; Otani K; Yasuda K; Kishikawa J; Nagai Y; Anzai H; Shinagawa T; Arakawa K; Yamaguchi H; Ishihara S; Sunami E; Kitayama J; Watanabe T
    Surg Today; 2016 Oct; 46(10):1115-22. PubMed ID: 26676416
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The additive effect of p53 Arg72Pro and RNASEL Arg462Gln genotypes on age of disease onset in Lynch syndrome patients with pathogenic germline mutations in MSH2 or MLH1.
    Krüger S; Engel C; Bier A; Silber AS; Görgens H; Mangold E; Pagenstecher C; Holinski-Feder E; von Knebel Doeberitz M; Royer-Pokora B; Dechant S; Pox C; Rahner N; Müller A; Schackert HK;
    Cancer Lett; 2007 Jul; 252(1):55-64. PubMed ID: 17224235
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Consideration of hereditary nonpolyposis colorectal cancer in BRCA mutation-negative familial ovarian cancers.
    South SA; Vance H; Farrell C; DiCioccio RA; Fahey C; Piver MS; Rodabaugh KJ
    Cancer; 2009 Jan; 115(2):324-33. PubMed ID: 19117025
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Detection mutations in the DNA mismatch repair genes of hMLH1 and hMSH2 genes in Colombian families with suspicion of hereditary non-polyposis colorectal carcinoma (Lynch syndrome)].
    Gómez A; Salguero G; García H; Aristizábal F; Gutiérrez O; Angel LA; Padrón J; Martínez C; Martínez H; Malaver O; Barvo R; Giraldo A
    Biomedica; 2005 Sep; 25(3):315-24. PubMed ID: 16276679
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Eight novel germline MLH1 and MSH2 mutations in hereditary non-polyposis colorectal cancer families from Spain.
    Godino J; de La Hoya M; Diaz-Rubio E; Benito M; Caldés T
    Hum Mutat; 2001 Dec; 18(6):549. PubMed ID: 11748856
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Causes of Cancer Death Among First-Degree Relatives in Japanese Families with Lynch Syndrome.
    Tanakaya K; Yamaguchi T; Ishikawa H; Hinoi T; Furukawa Y; Hirata K; Saida Y; Shimokawa M; Arai M; Matsubara N; Tomita N; Tamura K; Sugano K; Ishioka C; Yoshida T; Ishida H; Watanabe T; Sugihara K;
    Anticancer Res; 2016 Apr; 36(4):1985-9. PubMed ID: 27069191
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Two new MLH1 germline mutations in Brazilian Lynch syndrome families.
    Dominguez MV; Bastos EP; Santos EM; Oliveira LP; Ferreira FO; Carraro DM; Rossi BM
    Int J Colorectal Dis; 2008 Dec; 23(12):1263-4. PubMed ID: 18594839
    [No Abstract]   [Full Text] [Related]  

  • 54. [Tumor-infiltrating lymphocytes can be used to screen for lynch syndrome - a case report].
    Tanakaya K; Kanaya N; Shigeyasu K; Kunitomo T; Aoki H; Takeuchi H; Yamasaki R
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1602-4. PubMed ID: 25731267
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Coexistence of Peutz-Jeghers' syndrome and Lynch's syndrome in the same patient].
    Martínez Amate E; Carreño González R; Jorge Cerrudo J; Esteban Carretero J
    Gastroenterol Hepatol; 2012; 35(6):395-9. PubMed ID: 22516349
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genomics of Hereditary Colorectal Cancer: Lessons Learnt from 25 Years of the Singapore Polyposis Registry.
    Chew MH; Tan WS; Liu Y; Cheah PY; Loi CT; Tang CL
    Ann Acad Med Singap; 2015 Aug; 44(8):290-6. PubMed ID: 26477961
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New EPCAM founder deletion in Polish population.
    Dymerska D; Gołębiewska K; Kuświk M; Rudnicka H; Scott RJ; Billings R; Pławski A; Boruń P; Siołek M; Kozak-Klonowska B; Szwiec M; Kilar E; Huzarski T; Byrski T; Lubiński J; Kurzawski G
    Clin Genet; 2017 Dec; 92(6):649-653. PubMed ID: 28369810
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [A Case of Cecal Cancer Associated with Preoperatively Diagnosed Lynch Syndrome Caused by EPCAM Deletion].
    Yamamoto A; Eguchi H; Suzuki O; Chika N; Ito T; Tajima Y; Kamae N; Nagai T; Takai Y; Seki H; Akagi K; Okazaki Y; Ishida H
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):2202-2204. PubMed ID: 30692331
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of endoscopic submucosal dissection in a patient with synchronous and metachronous gastric cancers secondary to MSH2-related Lynch syndrome.
    Civitarese A; Farha N; Elsoukkary S; Bhatt A; Burke CA
    Gastrointest Endosc; 2024 Apr; 99(4):644-645. PubMed ID: 37806399
    [No Abstract]   [Full Text] [Related]  

  • 60. Primary malignant pericardial tumour in Lynch syndrome.
    Paolisso P; Saturi G; Foà A; Saponara M; Nannini M; Pantaleo MA; Leone O; Turchetti D; Calistri D; Savini C; Pacini D; Pizzi C; Galiè N
    BMC Cancer; 2020 Mar; 20(1):191. PubMed ID: 32143595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.